Researchers to observe how well current breast cancer drugs work in everyday care
NCT ID NCT07076680
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 22 times
Summary
This study aimed to collect information from routine medical care of people with a certain type of advanced breast cancer (HR+/HER2-). Researchers planned to track side effects and how well the treatment worked, without giving any new drugs or changing care. The study was withdrawn before enrolling any participants, so no data was collected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, China
Conditions
Explore the condition pages connected to this study.